Yarrow Bioscience holders report 1.16% beneficial stake
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Yarrow Bioscience, Inc. (YARW) is the issuer covered by an ownership amendment from AI Biotechnology LLC, Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik. It states that the four reporting persons ceased to be beneficial owners of more than 5% of the common stock on November 13, 2026.
The reporting persons each reported 178,179 shares (1.16%) as beneficially owned. That amount includes 22,331 common shares held directly by AI Biotechnology and pre-funded warrants exercisable for 155,848 shares. The three other reporting persons may be deemed to beneficially own these securities through the stated control relationships, but each disclaims beneficial ownership.
Key Figures
Key Terms
beneficial ownership regulatory
pre-funded warrants financial
disclaims beneficial ownership regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
When did the YARW reporting persons cease to own more than 5%?
AI-generated analysis. How Rhea-AI works. Not financial advice.